iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAlerus Financial Na
Latest Disclosed Ownership1,206 shares
Latest Disclosed Value $ 203,633
Alerus Financial Na reports 10.86% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 12, 2026 - Alerus Financial Na filed a 13F-HR form disclosing ownership of 1,206 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $203,633 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,353 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -10.86% during the quarter. The current value of the position is $158,046 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,206 -147 -10.86 204 -10.96 0.0101
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,353 0 0.00 228 16.92 0.0112
2025-11-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,353 0 0.00 195 14.04 0.0099
2025-08-13 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,353 1,353 171 0.0123
2025-02-12 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -1,405 -100.00 0 -100.00
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,405 1,405 205 0.0150
2023-05-15 2023-03-31 13F ISHARES TRUST ISHARES BIOTECH 464287556 0 -1,561 -100.00 0 -100.00
2023-02-14 2022-12-31 13F ISHARES TRUST ISHARES BIOTECH 464287556 1,561 1,561 205 0.0188
2022-11-14 2022-09-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 0 -2,097 -100.00 0 -100.00
2022-08-12 2022-06-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 2,097 -1,622 -43.61 247 -49.07 0.0228
2022-05-13 2022-03-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 3,719 -194 -4.96 485 -18.76 0.0414
2022-02-14 2021-12-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 3,913 -1,372 -25.96 597 -30.09 0.0487
2021-11-12 2021-09-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 5,285 -18,462 -77.74 854 -78.02 0.0778
2021-08-11 2021-06-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 23,747 -4,835 -16.92 3,886 -9.69 0.3919
2021-05-13 2021-03-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 28,582 6,414 28.93 4,303 28.14 0.4536
2021-02-12 2020-12-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 22,168 -337 -1.50 3,358 10.21 0.3411
2020-11-13 2020-09-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 22,505 10,140 82.01 3,047 80.30 0.3430
2020-08-14 2020-06-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 12,365 6,904 126.42 1,690 187.41 0.1987
2020-05-12 2020-03-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 5,461 -237 -4.16 588 -14.41 0.0814
2020-02-11 2019-12-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 5,698 -245 -4.12 687 16.24 0.0783
2019-11-13 2019-09-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 5,943 -27,895 -82.44 591 -83.99 0.0764
2019-08-13 2019-06-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 33,838 -8,448 -19.98 3,692 -21.91 0.4981
2019-05-06 2019-03-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 42,286 -25,838 -37.93 4,728 -28.04 0.6589
2019-02-04 2018-12-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 68,124 -369 -0.54 6,570 -21.34 1.0071
2018-11-13 2018-09-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 68,493 -1,262 -1.81 8,352 9.02 1.1424
2018-08-08 2018-06-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 69,755 -889 -1.26 7,661 1.59 1.0875
2018-05-09 2018-03-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 70,644 -9,044 -11.35 7,541 -11.37 1.0829
2018-02-14 2017-12-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 79,688 53,805 207.88 8,508 -1.46 1.2056
2017-11-13 2017-09-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 25,883 44 0.17 8,634 7.76 1.2577
2017-08-09 2017-06-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 25,839 -94 -0.36 8,012 5.34 1.1881
2017-04-27 2017-03-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 25,933 159 0.62 7,606 11.20 1.1664
2017-02-13 2016-12-31 13F ISHARES TRUST NASDQ BIO INDX 464287556 25,774 760 3.04 6,840 -5.52 1.1051
2016-11-10 2016-09-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 25,014 -3,248 -11.49 7,240 -0.45 1.1709
2016-08-11 2016-06-30 13F ISHARES TRUST NASDQ BIO INDX 464287556 28,262 28,262 7,273 1.2168
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.